Juergen Koenig, a board member of Eucck and president of Merck Korea, delivers a speech about Europe’s biosimilar market at the Inter-Biopharm Alliance 2012 forum yesterday in Seoul. Provided by Merck Korea
More in Industry
DSME fined ￦15.3 billion for mistreating subcontractors
Hyundai, Naver to work together on connected car systems
SK Telcom merges two security services subsidiaries
KDB requests sit-down with Asiana unions about takeover
Are you Taycan to me?